Desjardins Global Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $121K | Sell |
1,256
-56
| -4% | -$5.4K | 0.01% | 433 |
|
|
2023
Q3 | $116K | Buy |
1,312
+457
| +53% | +$40.4K | 0.01% | 446 |
|
|
2023
Q2 | $74.1K | Buy |
855
+89
| +12% | +$7.71K | 0.01% | 513 |
|
|
2023
Q1 | $74K | Sell |
766
-44
| -5% | -$4.25K | 0.01% | 493 |
|
|
2022
Q4 | $83K | Sell |
810
-3
| -0.4% | -$307 | 0.01% | 408 |
|
|
2022
Q3 | $68K | Sell |
813
-2
| -0.2% | -$167 | 0.01% | 411 |
|
|
2022
Q2 | $67K | Buy |
815
+246
| +43% | +$20.2K | 0.01% | 407 |
|
|
2022
Q1 | $43K | Sell |
569
-34
| -6% | -$2.57K | ﹤0.01% | 427 |
|
|
2021
Q4 | $53K | Buy |
+603
| New | +$53K | ﹤0.01% | 428 |
|